Breakthrough Study Reveals GLP-1 Drug’s Potential to Drastically Reduce Breast Cancer Risk
A recent study suggests that GLP-1 drugs may significantly lower breast cancer risk, offering new hope for those at risk. The research, highlighted in Imaging Technology News, demonstrates a notable reduction in breast cancer risk. Further research is needed to fully understand the drug’s effects.